{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:56:39Z","timestamp":1791309399312,"version":"4.3.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"DOI":"10.1093\/eurheartj\/ehi501","type":"journal-article","created":{"date-parts":[[2005,9,24]],"date-time":"2005-09-24T00:25:07Z","timestamp":1127521507000},"page":"2245-2250","source":"Crossref","is-referenced-by-count":64,"title":["High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure"],"prefix":"10.1093","volume":"26","author":[{"given":"Nicolas","family":"Lamblin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Mouquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Hennache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Dagorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Susen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Bauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"de Groote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,9,23]]},"reference":[{"key":"key\n\t\t\t\t20171012001010_EHI501C1","doi-asserted-by":"crossref","unstructured":"Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation1991;83:778\u2013786.","DOI":"10.1161\/01.CIR.83.3.778"},{"key":"key\n\t\t\t\t20171012001010_EHI501C2","unstructured":"Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation1993;87(suppl.):VI5\u201316."},{"key":"key\n\t\t\t\t20171012001010_EHI501C3","doi-asserted-by":"crossref","unstructured":"de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol2004;43:1584\u20131589.","DOI":"10.1016\/j.jacc.2003.11.059"},{"key":"key\n\t\t\t\t20171012001010_EHI501C4","doi-asserted-by":"crossref","unstructured":"Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol1998;31:391\u2013398.","DOI":"10.1016\/S0735-1097(97)00494-4"},{"key":"key\n\t\t\t\t20171012001010_EHI501C5","doi-asserted-by":"crossref","unstructured":"Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol2000;36:1587\u20131593.","DOI":"10.1016\/S0735-1097(00)00912-8"},{"key":"key\n\t\t\t\t20171012001010_EHI501C6","doi-asserted-by":"crossref","unstructured":"Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation2000;102:3060\u20133067.","DOI":"10.1161\/01.CIR.102.25.3060"},{"key":"key\n\t\t\t\t20171012001010_EHI501C7","doi-asserted-by":"crossref","unstructured":"Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol1996;27:1201\u20131206.","DOI":"10.1016\/0735-1097(95)00589-7"},{"key":"key\n\t\t\t\t20171012001010_EHI501C8","doi-asserted-by":"crossref","unstructured":"Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation2003;107:363\u2013369.","DOI":"10.1161\/01.CIR.0000053730.47739.3C"},{"key":"key\n\t\t\t\t20171012001010_EHI501C9","doi-asserted-by":"crossref","unstructured":"Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med1997;336:973\u2013979.","DOI":"10.1056\/NEJM199704033361401"},{"key":"key\n\t\t\t\t20171012001010_EHI501C10","doi-asserted-by":"crossref","unstructured":"Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA2001;285:2481\u20132485.","DOI":"10.1001\/jama.285.19.2481"},{"key":"key\n\t\t\t\t20171012001010_EHI501C11","doi-asserted-by":"crossref","unstructured":"Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem2001;47:418\u2013425.","DOI":"10.1093\/clinchem\/47.3.418"},{"key":"key\n\t\t\t\t20171012001010_EHI501C12","doi-asserted-by":"crossref","unstructured":"Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME Jr, Stevenson LW. 24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines\/prioritization. J Am Coll Cardiol1993;22:21\u201331.","DOI":"10.1016\/0735-1097(93)90812-F"},{"key":"key\n\t\t\t\t20171012001010_EHI501C13","doi-asserted-by":"crossref","unstructured":"Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation2003;107:499\u2013511.","DOI":"10.1161\/01.CIR.0000052939.59093.45"},{"key":"key\n\t\t\t\t20171012001010_EHI501C14","doi-asserted-by":"crossref","unstructured":"Stelken AM, Younis LT, Jennison SH, Miller DD, Miller LW, Shaw LJ, Kargl D, Chaitman BR. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol1996;27:345\u2013352.","DOI":"10.1016\/0735-1097(95)00464-5"},{"key":"key\n\t\t\t\t20171012001010_EHI501C15","doi-asserted-by":"crossref","unstructured":"Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet1997;349:462\u2013466.","DOI":"10.1016\/S0140-6736(96)07591-5"},{"key":"key\n\t\t\t\t20171012001010_EHI501C16","doi-asserted-by":"crossref","unstructured":"Alonso-Martinez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, Gonzalez-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail2002;4:331\u2013336.","DOI":"10.1016\/S1388-9842(02)00021-1"},{"key":"key\n\t\t\t\t20171012001010_EHI501C17","doi-asserted-by":"crossref","unstructured":"Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS, Lin SJ. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J2004;147:931\u2013938.","DOI":"10.1016\/j.ahj.2003.11.021"},{"key":"key\n\t\t\t\t20171012001010_EHI501C18","doi-asserted-by":"crossref","unstructured":"Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ2000;321:199\u2013204.","DOI":"10.1136\/bmj.321.7255.199"},{"key":"key\n\t\t\t\t20171012001010_EHI501C19","doi-asserted-by":"crossref","unstructured":"Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA, Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation2000;102:611\u2013616.","DOI":"10.1161\/01.CIR.102.6.611"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/26\/21\/2245\/9625113\/ehi501.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T21:50:26Z","timestamp":1586469026000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/eurheartj\/article\/26\/21\/2245\/443576\/Highsensitivity-Creactive-protein-potential"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,23]]},"references-count":19,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2005,9,23]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehi501","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11]]},"published":{"date-parts":[[2005,9,23]]}}}